Pauline Tibout

Noujaim J, Gupta AA, Holloway CL, Saleh R, Srikanthan A, Lemieux C, Soroka HP, Tibout P, Turcotte R, Feng X, Abdul Razak AR, Costa P

Corrigendum to "Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study" [Eur. J. Cancer, vol. 205 (2024) 114119]

Eur J Cancer, 208 , 2024.

| Liens:

Noujaim J, Gupta AA, Holloway CL, Saleh R, Srikanthan A, Lemieux C, Soroka HP, Tibout P, Turcotte R, Feng X, Abdul Razak AR, Costa P

Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study

Eur J Cancer, 205 , 2024.

Résumé | Liens:

Tibout P, Livingston J, Kanwar N, Yuki KE, Shlien A, Ngan B, Irwin MS, Morgenstern DA, Hitzler J, Villani A, Cohen-Gogo S

Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline SMARCA4 and EZH2 variants

Cold Spring Harb Mol Case Stud, 9 (4), 2023.

Résumé | Liens:

Tambasco D, Franklin M, Harris SA, Tibout P, Doria AS

A geospatial assessment of industrial releases and pediatric neuroblastic tumours at diagnosis: A retrospective case series

Arch Environ Occup Health, 78 (9-10), 2023.

Résumé | Liens:

Brizini M, Naccache L, Tibout P, Goudie C, Budd C, Vairy S, Brisson MC, Tran TH, Santiago R

Multicenter real-world experience of the clinical efficacy and tolerance of pazopanib in high-risk pediatric solid tumors (PazoPed)

Pediatr Hematol Oncol, 40 (7), 2023.

Résumé | Liens:

Castonguay M, Dakhallah N, Desroches J, Colaiacovo ML, Jimenez-Cortes C, Claveau AM, Bérubé S, Hafsaoui AY, Souza A, Tibout P, Ah-Yan C, Vincent AM, Naessens V, Brossard J, Abish S, Santiago R, Soulières D, Laroche V, Pastore Y, Tran TH, Forté S

COVID-19 and Sickle Cell Disease in the Province of Quebec, Canada: Outcomes after Two Years of the Pandemic

J Clin Med, 11 (24), 2022.

Résumé | Liens:

Tibout P, Ledjiar O, Athale U, Rayar M, Kulkarni K, Truong T, Cellot S, Bittencourt H, Pelland-Marcotte MC, Tran TH

Prognostic factors and outcomes of infant acute lymphoblastic leukemia (ALL), hypodiploid ALL, and mixed-phenotype acute leukemia (MPAL) in Canada: a report from CYP-C

Leuk Lymphoma, 63 (13), 2022.

Résumé | Liens:

Goudie C, Alayoubi AM, Tibout P, Duval M, Maranda B, Mitchell D, Mitchell JJ

Hematopoietic stem cell transplant does not prevent neurological deterioration in infants with Farber disease: Case report and literature review

JIMD Rep, 46 (1), 2019.

Résumé | Liens:

Tibout P, Rondeau-Legault J, St-Laurent G, Ferguson N, Simonyan D, Larouche V

Retrospective study of the radiological findings of the mediastinum after end-of-treatment for a mediastinal lymphomatous mass in pediatric oncology

Intern Med Rev (Wash D C), 5 (3), 2019.

| Liens:

Roussy M, Bilodeau M, Jouan L, Tibout P, Laramée L, Lemyre E, Léveillé F, Tihy F, Cardin S, Sauvageau C, Couture F, Louis I, Choblet A, Patey N, Gendron P, Duval M, Teira P, Hébert J, Wilhelm BT, Choi JK, Gruber TA, Bittencourt H, Cellot S

NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy

Genes Chromosomes Cancer, 57 (6), 2018.

Résumé | Liens: